ReviewMedical sciences (Basel, Switzerland)2016

Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma.

Ashutosh Chauhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.